Volume 20, Number 5—May 2014
Research
Persistence and Complex Evolution of Fluoroquinolone-Resistant Streptococcus pneumoniae Clone
Debby Ben-David
, Mitchell J. Schwaber, Amos Adler, Samira Masarwa, Rotem Edgar, Shiri Navon-Venezia, David Schwartz, Nurith Porat, Tali Kotlovsky, Nikolay Polivkin, Irina Weinberg, Avraham Lazary, Nissim Ohana, and Ron Dagan
, Mitchell J. Schwaber, Amos Adler, Samira Masarwa, Rotem Edgar, Shiri Navon-Venezia, David Schwartz, Nurith Porat, Tali Kotlovsky, Nikolay Polivkin, Irina Weinberg, Avraham Lazary, Nissim Ohana, and Ron Dagan
Table 3
Results of 3 point-prevalence surveys about Streptococcus pneumoniae conducted among residents in a post–acute care facility, Israel, 2006–2011*
| Survey and age group, y | No. patients screened | FQRSP |
FQISP |
FQ-susceptible S. pneumoniae |
|||||
|---|---|---|---|---|---|---|---|---|---|
| No. (%) | Serotype (no. isolates) | No. (%) | Serotype (no. isolates) | No. (%) | Serotype (no. isolates) | ||||
| First | |||||||||
| <18 | 15 | 0 | – | 2 (13) | 15A (1), 19F (1) | 2 (13) | 19F (2) | ||
| >18 |
69 |
10 (15) |
19F (6), 23F (4) |
0 |
_ |
6 (8) |
15A (1), 15B (2), 23F(1), 6A (2) |
||
| Second | |||||||||
| <18 | 24 | 0 | – | 0 | _ | 1 (4) | 15A (1) | ||
| >18 |
130 |
12 (9) |
23F (8), 19F (3); negative (1) |
0 |
_ |
2 (1) |
17F (1), 6A (1) |
||
| Third | |||||||||
| <18 | 25 | 0 | – | 2 (8) | 17F (1), 19F (1) | 4 (16) | 15A (3), 17F (1) | ||
| >18 | 140 | 19 (13) | 23F (12), 19F (7) | 0 | _ | 5 (3.6) | 17F (4), negative (1) | ||
*FQRSP, fluoroquinolone-resistant S. pneumoniae; FQISP, fluoroquinolone intermediate S. pneumoniae; FQ, fluoroquinolone; –, no isolates.
Page created: April 16, 2014
Page updated: April 16, 2014
Page reviewed: April 16, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.